Lv71
3320 积分 2022-10-22 加入
Clinical Presentation, Treatment Patterns, Burden of Disease, and the Association of Proteinuria with Clinical Outcomes in C3 Glomerulopathy and Primary Immune Complex Membranoproliferative Glomerulonephritis: A Systematic Review
6天前
已完结
Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN
6天前
已完结
Early eculizumab treatment improves renal outcomes in pediatric lupus nephritis with thrombotic microangiopathy
13天前
已完结
Clinicopathological landscape of lupus nephritis in Northeast China: A retrospective cohort study of determinants for moderate-to-severe renal dysfunction
13天前
已关闭
Treatment of lupus nephritis: consensus, evidence and perspectives
13天前
已完结
274MO Pooled efficacy and safety with tremelimumab plus durvalumab in participants (pts) with unresectable hepatocellular carcinoma (uHCC) from the mainland China extension cohort, and Hong Kong (HK) and Taiwan (TW) subgroups from the global cohort in the phase III HIMALAYA study
27天前
已关闭
[Chinese expert consensus on the diagnosis and treatment of dry eye (2024)]
1个月前
已完结
British Association of Dermatologists guidelines for the management of people with cutaneous lupus erythematosus 2021
1个月前
已完结
皮肤红斑狼疮治疗指南
1个月前
已完结
Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
皖公网安备34019202002308
